NEW YORK (GenomeWeb) – MDxHealth today reported that its fourth quarter revenues more than doubled year over year on a sharp rise in ConfirmMDx sales. 

The company said that total revenues increased to $3.4 million in the quarter, up from $1.6 million in Q4 2013. Revenues from the ConfirmMDx prostate cancer test rose to $2.4 million from $1.2 million as test volume increased 46 percent to more than 3,300 tests from 2,300 tests in the year-ago quarter. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.